Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets
PremiumCompany AnnouncementsZivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets
7M ago
Zivo starts efficacy study of immune modulating to treat coccidiosis in chickens
Premium
The Fly
Zivo starts efficacy study of immune modulating to treat coccidiosis in chickens
11M ago
Zivo Bioscience files to sell common stock, no amount given
Premium
The Fly
Zivo Bioscience files to sell common stock, no amount given
12M ago
Zivo Bioscience receives $1M bridge financing
PremiumThe FlyZivo Bioscience receives $1M bridge financing
1y ago
Zivo Bioscience price target lowered to $6 from $9 at Maxim
Premium
The Fly
Zivo Bioscience price target lowered to $6 from $9 at Maxim
2y ago
Zivo Bioscience reports results from coccidiosis trial in broiler chickens
Premium
The Fly
Zivo Bioscience reports results from coccidiosis trial in broiler chickens
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100